Mirae Asset Global ETFs Holdings’s Aquestive Therapeutics AQST Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	49,727 +1,944	+4%	+$8.18K	﹤0.01%	2467
2026 Q1	$198K	Sell	47,783 -710	-1%	-$2.88K	﹤0.01%	2366
2025 Q4	$313K	Buy	48,493 +9,074	+23%	+$56.5K	﹤0.01%	2135
2025 Q3	$220K	Sell	39,419 -7,679	-16%	-$33.2K	﹤0.01%	2272
2025 Q2	$156K	Buy	47,098 +2,649	+6%	+$7.6K	﹤0.01%	2398
2025 Q1	$129K	Buy	44,449 +1,872	+4%	+$5.67K	﹤0.01%	2515
2024 Q4	$152K	Buy	42,577 +1,824	+4%	+$8.41K	﹤0.01%	2526
2024 Q3	$203K	Buy	+40,753	New	+$159K	﹤0.01%	2372

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AQST Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aquestive Therapeutics (AQST) stake by 4.1% in Q2 2026, buying an estimated $8.18K and bringing the position to 49,727 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Mirae Asset Global ETFs Holdings first reported a position in AQST in Q3 2024 and has held it in 8 quarters since. The position peaked at $313K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Mirae Asset Global ETFs Holdings held 49,727 shares of Aquestive Therapeutics worth $207K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,944 Aquestive Therapeutics shares in Q2 2026, an estimated $8.18K.
Aquestive Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2467 holding.
Mirae Asset Global ETFs Holdings first reported a position in Aquestive Therapeutics in Q3 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Aquestive Therapeutics position peaked at $313K in Q4 2025.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.